Supernus Pharmaceuticals, Inc. v. Reich Consulting Group, Inc.

CourtCourt of Chancery of Delaware
DecidedOctober 29, 2021
DocketC.A. No. 2020-0217-MTZ
StatusPublished

This text of Supernus Pharmaceuticals, Inc. v. Reich Consulting Group, Inc. (Supernus Pharmaceuticals, Inc. v. Reich Consulting Group, Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Supernus Pharmaceuticals, Inc. v. Reich Consulting Group, Inc., (Del. Ct. App. 2021).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

SUPERNUS PHARMACEUTICALS, ) INC., ) ) Plaintiff/Counterclaim ) Defendant, ) ) v. ) C.A. No. 2020-0217-MTZ ) REICH CONSULTING GROUP, INC., ) ) Defendant/Counterclaim ) Plaintiff. )

POST-TRIAL FINAL ORDER AND JUDGMENT

WHEREAS, Supernus Pharmaceuticals, Inc., (“Supernus,” “Plaintiff,” or

“Counterclaim Defendant”), Supernus Merger Sub, Inc., Biscayne

Neurotherapeutics, Inc. (“Biscayne” or the “Company”), and Reich Consulting

Group, Inc. (“Reich,” “Defendant,” or “Counterclaimant”) entered into a merger

agreement on September 12, 2018 (the “Merger Agreement”);1

WHEREAS, on March 23, 2020, Supernus filed a verified complaint seeking

indemnification for breaches of the Merger Agreement, and on May 1, Reich filed a

verified answer and counterclaim seeking declaratory judgment and

indemnification;

1 Capitalized terms not defined herein have the same meaning as used in the Answer and Counterclaim at Docket Item (“D.I.”) 6 and the Merger Agreement. WHEREAS, on June 23, Reich filed a Motion for Partial Judgment on the

Pleadings, which the Court heard on January 12, 2021, and granted in part;2

WHEREAS, before trial, Supernus withdrew its indemnification claims

regarding Biscayne’s 2017 U.S. tax return (the “2017 Tax Claim”);

WHEREAS, I held a half-day trial on the papers on the remaining claims on

September 10, 2021; considered the parties’ pre- and post-trial submissions; and

grant the evidence the weight and credibility I find it deserves;3

NOW THEREFORE, this 29th day of October, 2021, the Court finds and

orders as follows:

1. Supernus is a pharmaceutical company incorporated in Delaware.4

Pursuant to the terms of the Merger Agreement, Supernus acquired Biscayne, a

biotech startup, for an initial payment of $15 million.5 The Merger Agreement was

extensively negotiated between the parties and contained relatively standard

provisions regarding integration, indemnification, representations and warranties,

and the creation of an escrow fund to deal with post-closing disputes.6 Reich serves

2 D.I. 8; D.I. 24; D.I. 26. 3 Citations to trial exhibits are in the form “JX —.” The Joint Pre-Trial Stipulation and Order, available at D.I. 69, is cited as “PTO ¶ —.” And citations to the trial transcript, available at D.I. 76, are in the form “Tr. —.” 4 PTO ¶ II.A.1; JX 6 at 1 [hereinafter “Merger Agr.”]. 5 PTO ¶¶ I.A, I.B.1, II.A.3; Merger Agr. at 3. 6 PTO ¶¶ II.B.5–9.

2 as Biscayne’s Securityholder Representative, and Citibank, N.A. serves as the

escrow agent for the parties under an Escrow Agreement dated October 4, 2018.7

Supernus Is Not Entitled To Indemnification Or Fees.

2. Supernus’s Count I asserted several claims for indemnification based

on breaches of representations and warranties in the Merger Agreement. Post-trial,

Supernus claims only that it is entitled to indemnification for Biscayne’s alleged

breach of Section 6.01 (the “Ordinary Course Covenant”) in the Merger Agreement.8

But the Ordinary Course Covenant did not survive Closing, and Supernus did not

bring a timely claim for breach of the Ordinary Course Covenant before it expired.

3. Section 6.01 bound Biscayne to operate in the ordinary course of

business “from the date of this Agreement until . . . the Effective Time.”9 The

“Effective Time” is “the time when the Certificate of Merger ha[s] been duly filed

with the Delaware Department of State or at such later time as may be agreed by

7 PTO ¶¶ II.A.4, II.B.6, II.C.10. 8 PTO ¶ I.A (“Counts I and II of Supernus’[s] Complaint seek indemnification for breaches of representations, warranties and covenants set forth in Sections 4.06, 4.07, and 6.01(a) of the Merger Agreement.”). At trial, Supernus effectively withdrew its only other live claim for breach, which asserted Biscayne breached its representations and warranties under Sections 4.06 and 4.07 regarding Financial Statements and Liabilities. Tr. 11 (“THE COURT: So everyone agrees that these accounts—the accounts payable statement in JX 5 accurately reflected these amounts that were due and owing, and we don’t have a breach of 4.06. Is that correct? MS. FENTON: Correct. I’m really looking at 6.01(a).”). 9 Merger Agr. § 6.01(a).

3 [Supernus] and [Biscayne] in writing and specified in the Certificate of Merger.” 10

Thus, the Ordinary Course Covenant bound Biscayne between September 12, 2018,

when the parties executed the Merger Agreement,11 and October 4, when the

Certificate of Merger was filed.12 Under Section 8.01(a), “[t]he covenants and

agreements contained herein that are to be performed at or prior to the Closing shall

not survive the Closing.”13 The Closing occurred no later than October 4.14

4. Supernus had to give notice of its claim for indemnification of the

Ordinary Course Covenant before the covenant expired. Section 8.01(b) provides:

10 Merger Agr. § 2.03. 11 PTO ¶ II.B.6. 12 D.I. 80, Certificate of Merger. While the Certificate of Merger was submitted after trial, this Court may take judicial notice of it. See, e.g., In re Cadira Gp. Hldgs., LLC Litig., 2021 WL 2912479, at *8 n.74 (Del. Ch. July 12, 2021) (collecting cases). 13 Merger Agr. § 8.01(a). 14 D.I. 6, Verified Answer and Counterclaim of Reich Consulting Group, Inc. ¶ 11 [hereinafter “Counterclaim”]; D.I. 7, Supernus Pharmaceuticals, Inc.’s Answer to Counterclaim of Reich Consulting Group, Inc., at 5 ¶ 2. Compare Merger Agr. § 2.02 (“The date on which the Closing occurs is referred to in this Agreement as the ‘Closing Date.’” (emphasis omitted)), with id. § 2.03 (defining “Effective Time” as “the time when the Certificate of Merger ha[s] been duly filed with the Delaware Department of State or at such later time as may be agreed by [Supernus] and [Biscayne] in writing and specified in the Certificate of Merger.”). Reich argues “the intent of the agreement is for the Closing and the Effective Time to be simultaneous.” D.I. 79 at 3. I need not reconcile these dates.

4 No claim for indemnification for breach of any . . . covenant contained in this Agreement . . . may be asserted pursuant to this Agreement unless prior to the expiration of the applicable survival period specified in Section 8.01(a), such claim is asserted by proper written notice in accordance with this Article VIII . . . .15

Supernus submitted indemnification claim notices to Reich on January 21, 2019,16

October 25, 2019,17 and March 26, 202018—each after Closing on October 4, 2018.

5. The parties did not address before or during trial whether Supernus’s

indemnification claim notices were timely in view of the Ordinary Course

Covenant’s survival period.19 Nevertheless, in considering Supernus’s contractual

indemnification claim, the Court must read the Merger Agreement as a whole.20 “To

determine what contractual parties intended, Delaware courts start with the text.” 21

15 Merger Agr. § 8.01(b) (emphasis omitted). 16 PTO ¶ II.D.12; JX 8. 17 PTO ¶ II.D.13; JX 11. 18 PTO ¶ II.D.14; JX 17. 19 See D.I. 72 at 2 (“Given that the parties are now focused on the alleged breach of Section 6.01, I invite the parties to submit simultaneous letter briefing on whether the post-closing ordinary course claim is viable.”). The parties filed post-trial submissions on September 20, 2021. D.I. 77; D.I. 79. 20 PTO ¶¶ I.A, II.D.12–14; Merger Agr. §§ 6.01, 8.01, 8.02; E.I. du Pont de Nemours & Co., Inc. v. Shell Oil Co., 498 A.2d 1108, 1113 (Del.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lemon v. Kurtzman
411 U.S. 192 (Supreme Court, 1973)
Minnesota Invco of RSA 7, Inc. v. Midwest Wireless Holdings LLC
903 A.2d 786 (Court of Chancery of Delaware, 2006)
IBP, Inc. v. Tyson Foods, Inc.
793 A.2d 396 (Court of Chancery of Delaware, 2002)
Kronenberg v. Katz
872 A.2d 568 (Court of Chancery of Delaware, 2004)
Crescent/Mach I Partners L.P. v. Dr Pepper Bottling Co.
962 A.2d 205 (Supreme Court of Delaware, 2008)
Tyson Foods, Inc. v. Aetos Corp.
818 A.2d 145 (Supreme Court of Delaware, 2003)
Stroud v. Milliken Entersprises, Inc.
552 A.2d 476 (Supreme Court of Delaware, 1989)
In Re IBP, Inc., Shareholders Litigation
789 A.2d 14 (Court of Chancery of Delaware, 2001)
E.I. Du Pont De Nemours & Co. v. Shell Oil Co.
498 A.2d 1108 (Supreme Court of Delaware, 1985)
Johnston v. Arbitrium (Cayman Islands) Handels AG
720 A.2d 542 (Supreme Court of Delaware, 1998)
Peden v. Gray
886 A.2d 1278 (Supreme Court of Delaware, 2005)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Klig v. DELOITTE LLP
36 A.3d 785 (Court of Chancery of Delaware, 2011)
Twin City Fire Insurance v. Delaware Racing Ass'n
840 A.2d 624 (Supreme Court of Delaware, 2003)
Ramos v. Westlake Services CA1/2
242 Cal. App. 4th 674 (California Court of Appeal, 2015)
RBC Capital Markets, LLC v. Jervis
129 A.3d 816 (Supreme Court of Delaware, 2015)
Eagle Force Holdings, LLC v. Campbell
187 A.3d 1209 (Supreme Court of Delaware, 2018)
Sunline Commercial Carriers, Inc. v. Citgo Petroleum Corporation
206 A.3d 836 (Supreme Court of Delaware, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Supernus Pharmaceuticals, Inc. v. Reich Consulting Group, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/supernus-pharmaceuticals-inc-v-reich-consulting-group-inc-delch-2021.